
Opinion|Videos|February 14, 2025
Importance of Multidisciplinary Approach in Care of CAR-T MM Patients
This segment explores Dr. Rossi's clinical experience with cilta-cel as a second-line therapy, focusing on its efficacy and quality-of-life benefits across diverse patient populations.
Advertisement
Video content above is prompted by the following:
- Can you share your experience with cilta-cel as a second-line therapy?
- What advantages in terms of efficacy and quality of life have you noted across various patient populations?
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel 4-Biomarker Panel Improves Early Detection of Pancreatic Cancer
2
Bria-IMT Continues to Improve Survival in Metastatic Breast Cancer
3
Heavy, Consistent Alcohol Intake Increases Risk of Colorectal Cancer
4
FDA Type B Meeting Elucidates Testosterone-Associated Breast Cancer Risks
5


































